Special Issue "Advances in Fatty Acid Metabolism as the Markers of Civilization Diseases 2.0"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 1003
Interests: fatty acids metabolism; inflammatory process; eicosanoids; SCFA; PUFA; MUFA; nutriepigenomics; chromatography; ischemic stroke; NAFLD; NASH
Special Issues, Collections and Topics in MDPI journals
Fatty acids (FA), as the basic component of cell membranes, participate in maintaining the homeostasis of cellular metabolism, cell signaling and gene expression. Fatty acids are a biochemically diverse group of organic compounds in terms of their structure and origin. Regulatory functions in humans body are performed by both SCFA short-chain fatty acids, produced by the bacteria from gut microbiome, and dietary fatty acids, mainly PUFA n3 and n6. The FA are very important factors modifying a number of metabolic pathways in our body, and at the same time being their components. Eicosanoids, EPA and DHA derivatives, such as prostaglandins, leukotrienes, resolvins, protectins and maresins, are anti-inflammatory or pro-inflammatory mediators. Low-intensity inflammation may be associated with susceptibility to developing non-communicable chronic diseases (NCCD), such as obesity, lipid disorders and NAFLD, cardiovascular diseases (CVD), type 2 diabetes (T2D), insulin resistance , or some types of cancers. It is also believed that disturbance of lipid homeostasis is also associated with neurological disorders as well as neurodegenerative diseases such as Alzheimer's disease (AD).
I have hope that the recent advances in lipidometabolomics help a better understanding of the role of some nutritional factors, including fatty acids, in the development of civilization diseases. It is possible that understanding the fatty acid profile in these diseases will allow for the development of new diagnostic, therapeutic, and prophylactic strategies. I invite scientists to share their experiences in this area in the form of original research and review articles.
Dr. Arleta Drozd
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- fatty acids
- pathophysiological mechanisms
- lipid mediators
- gut microbiota
- insulin resistance
- type 2 diabetes
- endocine diseases
- cardiovascular diseases